Clinical comparison of histamine H1-receptor antagonist drugs

Journal of Allergy and Clinical Immunology

Volumn 98, Issue 6 SUPPL. 2, 1996, Pages

  Du Buske, Lawrence M ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b IRINE   (United States)

Author keywords

Allergy therapy; Antihistamines; H1 receptor antagonists

Indexed keywords

ACRIVASTINE; ANTIHISTAMINIC AGENT; ASTEMIZOLE; CETIRIZINE; CHLORPHENIRAMINE; CLARITHROMYCIN; DIPHENHYDRAMINE; ERYTHROMYCIN; FEXOFENADINE; HYDROXYZINE; ITRACONAZOLE; KETOCONAZOLE; LORATADINE; TERFENADINE; TRIPROLIDINE;

ALLERGIC DISEASE; ALLERGIC RHINITIS; ANOREXIA; BLOOD BRAIN BARRIER; CARDIOTOXICITY; DRUG EFFICACY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG UPTAKE; HUMAN; HYPOKALEMIA; HYPOMAGNESEMIA; LIVER FAILURE; PRIORITY JOURNAL; RECEPTOR AFFINITY; REVIEW; SOMNOLENCE; URTICARIA;

EID: 0030445520     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(96)70058-1     Document Type: Article

References (85)

1. 1-receptor-antagonist drugs. N Engl J Med 1994;330:1663-9.
2. Turkeltaub PC, Gergen PJ. Prevalence of upper and lower respiratory conditions in the US population by social and environmental factors: data from the second National Health and Nutrition Examination Survey, 1976 to 1980: NHANES II. Ann Allergy 1991;67:147-54.
3. Meltzer EO. An overview of current pharmacotherapy in perennial rhinitis. J Allergy Clin Immunol 1995;95:1097-110.
4. Masheter HC. Terfenadine: the first second-generation antihistamine. Clin Rev Allergy 1993;11:5-34.
5. Wasserman SI. Histamine and the preclinical pharmacology of cetirizine. Ann Allergy 1987;59:1-3.
6. Arrang JM. Pharmacological properties of histamine receptor subtypes. Cell Mol Biol 1994;40:273-9.
7. Holgate ST, Abraham WM, Barnes PS, Lee TH. The role of inflammatory processes in airway hyperresponsiveness. ST Holgate, editor. Oxford: Blackwell, 1989:179-221
8. Prenkowski MM, Adkinson NF Jr, Plaut M, Norman PS, Lichtenstein LM. Prostaglandin D2 and histamine during the immediate and late-phase components of allergic cutaneous response. J Allergy Clin Immunol 1988;82:95-100.
9. Watson WTA, Simons KJ, Chen XY, Simons FER. Cetirizine: a pharmacokinetic and pharmacodynamic evaluation in children with seasonal allergic rhinitis. J Allergy Clin Immunol 1989;84:457-64.
10. 1-receptor antagonist: effect in allergic rhinoconjunctivitis, on antigen and histamine induced skin wheal responses and relationship to serum levels. Br J Clin Pharmacol 1984;18:1-8.
11. Simons FER, Murray HE, Yi Z, Simons KJ. Cetirizine and hydroxyzine concentrations in human skin [abstract]. J Allergy Clin Immunol 1994;93:222.
12. 1-receptor antagonist therapy. Clin Pharmacokinetics 1991;21:372-93.
13. De Vos C, Malefix M-R, Baltes E, Golbert J. Inhibition of histamine and allergen skin wheal by cetirizine in four animal species. Ann Allergy 1987;59:278-82.
14. Naclerio RM, Porud D, Kagey-Sobotka A, Freidhoff L, Norman PS, Lichtenstein LM. The effect of cetirizine on early allergic response. Laryngoscope 1989;99:596-9.
15. Canonica GW, Pronzato C, Fiorino N, Ciprandi G, Bagnasco M. Adhesional molecules: a review of their clinical roles in allergic inflammation. ACI News 1993;5:80-4.
16. Simons FR, McMiilan JL, Simons KJ. A double-blind, single-dose crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo, suppression effects on histamine-induced wheats and flares during 24 hours in normal subjects. J Allergy Clin Immunol 1990;86:540-7.
17. Meltzer EO. Antihistamine and decongestant-induced performance decrements. J Occupational Med 1990;32:327.
18. Wyngaarden JB, Seevers MH. The toxic effects of antihistaminic drags. JAMA 1951;145:277-82.
19. 1-receptor antihistamines. Ann Allergy 1991;67:625-33.
20. 1-receptor antagonists: comparative tolerability and safety. Drug Safety 1994;10:350-80.
21. Bantz EW, Dolen WK, Chadwick EW, Nelson HS. Chronic chlorpheniramine therapy: subsensitivity, drug metabolism and compliance. Ann Allergy 1987;59;341-6.
22. Vuurman EFPM, van Veggel LMA, Uiterwijk MMC, Leutner Detlev, O'Hanlon JF. Seasonal allergic rhinitis and antihistamine effects on children's learning. Ann Allergy 1993;71:121-6.
23. 21b. Gilmore TM, Alexander BH, Mueller BA, Revara FP. Occupational injuries and medication use. Am J Industrial Med 1996;30:234-9.
24. Alford C, Rombaut N, Jones J, Foley S, Idzikowski C, et al. Acute effects of hydroxyzine on nocturnal sleep and sleep tendency the following day: a C-EEG study. Human Psychopharmacol 1992;7:25-35.
25. Goetz DW, Jacobson JM, Apaliski SJ, Repperger DW, Martin ME. Objective antihistamine side effects are mitigated by evening dosing of hydroxyzine. Ann Allergy 1991;67:448-54.
26. Goetz DW, Jacobson JM, Mumane JE, et al. Prolongation of simple and choice reaction time in a double-blind comparison of twice-daily hydroxyzine versus terfenadine. J Allergy Clin Immunol 1989;84:316-22.
27. Seidel WF, Cohen S. Bliwise NG, Dement WC. Direct measurement of daytime sleepiness after administration of cetirizine and hydroxyzine with a standardized EEG assessment. J Allergy Clin Immunol 1990;86:1029-33.
28. Cimbura G, Lucas DM, Bennett RC, Warren RA, Simpson HM. Incidence and toxicological aspects of drugs detected in 484 fatally injured drivers and pedestrians in Ontario. Forensic Sci 1982;27:855-67.
29. Warren R, Simpson H, Hilchie J, Cimbura G, Lucas D, et al. Drugs detected in fatally injured drivers in the province of Ontario. In: Goldburg L, editor. Alcohol, drugs and traffic Safety, vol. 1. Stockholm: Almquist & Wiksell, 1981:203-17.
30. Grant SM, Goa KL, Fitton A, Sorking EM. Ketotifen: a review of its pharrnacodynamic and pharraacokinetic properties, and therapeutic use in asthma and allergic disorders. Drugs 1990;40:412-48.
31. Janssens MM-L. Astemizole: a non-sedating antihistamine with fast and sustained activity. Gin Rev Allergy 1993;11:35-63.
32. Simons FER, Watson WTA, Simons KJ. Lack of subsensitivity to terfenadine during long-term terfenadine treatment. J Allergy Clin Immunol 1988;82:1068-75.
33. Bousquet J, Chanal I, Skass-Brociek W, Lemonier C, Michel FB. Lack of subsensitivity to loratadine during long-term dosing during 12 weeks. J Allergy Clin Immunol 1990;86:248-53.
34. Juniper EF, White J, Dolovich J. Efficacy of continuous treatment with astemizole and terfenadine in ragweed pollen-induced rhinoconjunctivitis. J Allergy Clin Immunol 1988;82;670-5.
35. Sorkin BM, Heel RC. Terfenadine: a review of its pharrnacodynamic properties and therapeutic efficacy. Drugs 1985;29:34.
36. Panayotopoulos SM, Panayotopoulou ES, Efficacy of cetirizine in the treatment of seasonal allergic rhinoconjunctivitis. Ann Allergy 1990;65:146-8.
37. DuBuske LM. Dose-ranging comparative evaluation of cetirizine in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1995;74:345-53.
38. Smith SJ. Cardiovascular toxicity of antihistamines. Otolaryngol Head Neck Surg 1994;111:348-54.
39. 36a. Bernstein DI, Schoenwetter W, Nathan R, et al. Fexofenadine: a new nonsedating antihistamine is effective in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1996;97:435.
40. Busse W: Role of antihistamines in allergic disease. Ann Allergy 1994;72:371-5.
41. Mauser PJ, Kreutner W, Egan RW, Chapman RW. Selective inhibition of peripheral histamine responses by loratadine and terfenadine. Eur J Pharmacol 1990;182;125-9.
42. Cohen AF, Hamilton M, Phillipson R, Peck AW. The acute effects of acrivastine (BW825C), a new antihistamine compared with triprolidone on measures of CNS performance and subjective effects. Clin Pharmacol Ther 1985;38:381-6.
43. Spencer CM, Faulds D, Peters DH. Cetirizine: a reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders. Drugs 1993;46:1055-80.
44. 1 activation in human liver microsomes by naringenin and other flavonoids. Carcinogen 1992;11:2275-9.
45. Sale ME, WoosIcy RL, Barby JT, Yeh J, Chung M. Lack of electrocardiographic effects of cetirizine in healthy humans. J Allergy Clin Immunol 1993;91:258.
46. Honig PK, Wortham DC, Zamani K, Conner DP, Muilin JC, Cantilena LR. Terfenadine-ketoconazole interaction. JAMA 1993;12:1513-8.
47. Honig PK, Woosleu RL, Zamani K, Conner DP, Cantilena LR Jr. Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther 1992;52:231-8.
48. Day CP, James OFW, Butler TJ, Campbell RWF. QT prolongation and sudden cardiac death in patients with alcoholic liver disease. Lancet 1993;341:1423-8.
49. Pratt CM, Hertz RP, Ellis BE, Shaw M, Crowell SP, et al. What is the risk of developing life-threatening ventricular arrhythmia on terfenadine? interpretation and limitations of an observational cohort study. Am J Cardiol, 1994. In press.
50. Hanrahan JP, Choo PW, Carlson W, Greineder D, Faich GA. et al. Antihistamine-associated sudden death, ventricular arrhythmias, syncope and QT-prolongation: a comparison of terfenadine and other antihistamines. Postmarketing Surveillance 1992;6:23-4.
51. Honig PK, Wortham DC, Zamani K, Mullin JC, Conner DP, et al. The effect of fluconazole on the steady-state pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine in humans. Clin Pharmacol Ther 1993;53:630-6.
52. Thompson D, Oster G. Use of terfenadine and contraindicated drugs. JAMA 1996;275:1339-41.
53. Sanders RL, Dockhom RJ, Alderman JL, McSorley PA, Wenger TL, et al. Cardiac effects of acrivastine compared to terfenadine. J Allergy Clin Immunol 1992;89:183.
54. Piepho RW. Current status of second-generation antihistamines. Intern Med Alert 1993;15/16:126-7.
55. Ben-David J, Zipes DP. Torsades de pointes and proarrhythmia. Lancet 1993;341:1578-82.
56. Good AP, Rockwood R, Schad P. Loratadine and ventricular tachycardia. Am J Cardiol 1994;74:207-9.
57. Togias AG, Naclerio RM, Warner J, et al. Demonstration of inhibition of mediator release from human mast cells by azatadine base: in vivo and in vitro evaluation. JAMA 1986;255:225-9.
58. 1-receptor antagonists assessed by nasal challenge. J Allergy Clin Immunol 1988;82:881-7.
59. Michel L, De Vos C, Dubertret L. Cetirizine effects on the cutaneous allergic reaction in humans. Ann Allergy 1990;65:512-6.
60. Charlesworth EN, Kagey-Sobotka A, Nonnan PS, et al. Effect of cetirizine on mast cell mediator release and cellular traffic during the cutaneous late-phase reaction. J Allergy Clin Immunol 1989;83:905-12.
61. Redier H, Chanez P, DeVos C, et al. Inhibitory effect of cetirizine on the bronchial eosinophil recruitment induced by allergen inhalation challenge in allergic patients with asthma. J Allergy Clin Immunol 1992;90:215-24.
62. Ciprandi G, Buscaglia S, Pesce G, et al. Ceterizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge. J Allergy Clin Immunol 1995;95:612-21.
63. Fadel R, David B. Herpein-Richard N, et al. Effects of cetirizine on human eosinophil and neutrophil activation in vitro. Int Arch Allergy Appl Immunol 1991;95;158-62.
64. Walsh GM, Moqbel R, Harmell A, et al. Effects of cetirizine on human eosinophil and neutrophil activation in vitro. Intern Arch Allergy Appl Immunol 1991;95:158-62.
65. Coyle A J, Lefort J, Vargaftig BB. The effect of cetirizine on antigen-dependent leukopenia in the guinea-pig. Br J Pharmacol 1991:103;1520-4.
66. Togias AG, Proud D, Kagey-Sobotka A, Freidhoff L, Lichtenstein LM, Naclerio RM. In vivo and in vitro effects of antihistamines on mast cell mediator release: a potentially important property in the treatment of allergic disease. Ann Allergy 1989;63:465-89.
67. Naclerio RM. The effect of antihistamines on the immediate allergic response. Otolaryngol Head Neck Surg 1993;108:723-30.
68. 2-receptors in pulmonary and systemic vasculature of the dog. Am J Physiol 1975;229;1008-13.
69. 1 blocker, chlorpheniramine. J Allergy Clin Immunol 1977;59:54-63.
70. Groggins RC, Milner AD, Stokes GM. The bronchodilator effects of chlorpheniramine in childhood asthma. Br J Dis Chest 1979;73:297-301.
71. Schuller DE. Adverse effects of brompheniramine on pulmonary function in a subset of asthmatic children. J Allergy Clin Immunol 1983;72:175-9.
72. Lewiston NJ, Johnson S, Sloan E. Effect of antihistamines on pulmonary function of children with asthma. J Pediatr 1982;101:458-60.
73. Karlin JM. The use of antihistamines in asthma. Ann Allergy 1972;30:342-7.
74. American Academy of Allergy and Immunology. The use of antihistamines in patients with asthma. J Allergy Clin Immunol 1988;82:481-2.
75. Bousquet J. Emonot A, Germouty J, et al. Double-blind multicenter study of cetrizine in grass-pollen-induced asthma. Ann Allergy 1990;65:504-7.
76. Buttmann G, Pedrali P, Arendt C, Rihoux JP. Protective effect of cetirizine in patients suffering from pollen asthma. Ann Allergy 1990;64:224-8.
77. Storms W, Middleton E, Dvorin D, Kemp J, Spector SL, Newton J, et al. [abstract]. J Allergy Clin Immunol 1989;75:167.
78. 1-receptor antagonist in asthmatic airways. Am Rev Respir Dis 1987;135:181-4.
79. Finnerty JP, Holgate ST. Eur Respir J 1989;140:593-7.
80. Clee MD, Ingram CG, Reid PC, Robertson AS. The effect of astemizole on exercise-induced asthma. Br J Dis Chest 1984;78:180-3.
81. Cistero A, Abadias M, Lieonaart R. Effect of astemizole on allergic asthma. Ann Allergy 1992;69:123-7.
82. Kopferschmitt-Kubler MC, Couchot A, Pauli G. Evaluation of the effect of oral cetirizine on antigen-induced immediate asthmatic responses. Ann Allergy 1990;65:501-3.
83. Redier H, Chanez P, De Vos C, Rifai N, Clauzel AM, et al. Inhibition of effect of cetirizine on the bronchial eosinophil recruitment induced by allergen inhalation challenge in allergic patients with asthma. J Allergy Clin Immunol 1992;90:215-24.
84. Grant JA, Nicodemus CF, Findlay SR, et al. Ceterizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 1995;95:923-32.
85. Spector SL, Nicodemus CF, Corren J, Shanher HM, Rachelfsky GS, et al. Comparison of the bronchodilatory effects of cetirizine, albuterol, and both together versus placebo in patients with mild to moderate asthma. J Allergy Clin Immunol 1995;96:174-81.